Subgroup analysis by treatment group | Apixaban | Placebo | |||
---|---|---|---|---|---|
Events | Patients | Events | Patients | RR (95% CI) | |
Overall |
|
||||
Apixaban, 2.5 mg | 27 | 840 | 22 | 826 |
|
Apixaban, 5 mg | 35 | 811 |
|
||
Weight, kg |
|
||||
≤60 |
|
||||
Apixaban, 2.5 mg | 3 | 58 | 1 | 47 |
|
Apixaban, 5 mg | 7 | 58 |
|
||
>60 |
|
||||
Apixaban, 2.5 mg | 24 | 780 | 20 | 776 |
|
Apixaban, 5 mg | 28 | 750 |
|
Favors apixaban
Apixaban 2.5 mg BID
Apixaban 2.5 mg BID
Favors placebo
Apixaban 5 mg BID
Apixaban 5 mg BID